| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.097 | 0.004 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.004 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.091 | 0.005 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.006 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.091 | 0.007 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.009 |